The most recent Health Matters reporting.
05.11.2026
Essential medicine shortages threaten 165 public sector products in South Africa. See what is disrupting supply and how the department is responding.
05.11.2026
Retail pharmacy competition is squeezing Dis-Chem’s earnings as Clicks expands loyalty discounts. Shoprite’s Sixty60 is also in focus.
05.11.2026
Value-based care could help South Africa curb private healthcare costs while NHI remains contested. Read why payment reform need not wait.
03.11.2026
A KeyHealth PMB ruling orders full funding for treatment for a teenager’s rare blood disorder. The scheme plans to challenge the decision.
03.11.2026
Aspen Ovestin sale will raise €197m while preserving a manufacturing role. Explore the deal terms and implications for its portfolio strategy.
02.11.2026
A healthcare consensus initiative seeks agreement on universal coverage and action on failing services. Read about its priorities.
02.11.2026
Explore the Dis-Chem digital platform and see how it connects prescriptions and shopping in a seamless online experience.
30.10.2026
Western Cape urges national action on medicine shortages and possible port delays affecting public healthcare.
30.10.2026
China clinical trials offer drugmakers lower costs and faster recruitment, but safety and data concerns persist.
28.10.2026
Medical scheme increases in 2027 range from 7.35% to 8.9%. Ageing members, chronic illness and medicine costs drive contributions higher.
28.10.2026
GLP-1 obesity treatment remains unavailable in the public sector as officials delay a review despite WHO guidance. Read about the barriers.
27.10.2026
Aspen Manufacturing to more than double EBITDA in 2027 as sterile operations, insulin and new production lines replace a lost mRNA deal.